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ABSTRACT
Withholding or withdrawing life-saving ventilators can
become necessary when resources are insufficient. In the
USA, such rationing has unique social justice dimensions.
Structural elements of dominant allocation frameworks
simultaneously advantage white communities, and
disadvantage Black communities—who already
experience a disproportionate burden of COVID-19-
related job losses, hospitalisations and mortality. Using
the example of New Jersey’s Crisis Standard of Care
policy, we describe how dominant rationing guidance
compounds for many Black patients prior unfair
structural disadvantage, chiefly due to the way creatinine
and life expectancy are typically considered.
We outline six possible policy options towards a more
just approach: improving diversity in decision processes,
adjusting creatinine scores, replacing creatinine, dropping
creatinine, finding alternative measures, adding equity
weights and rejecting the dominant model altogether.
We also contrast these options with making no changes,
which is not a neutral default, but in separate need
of justification, despite a prominent claim that it is
simply based on ’objective medical knowledge’. In the
regrettable absence of fair federal guidance, hospital and
state-level policymakers should reflect on which of these,
or further options, seem feasible and justifiable.
Irrespective of which approach is taken, all guidance
should be supplemented with a monitoring and reporting
requirement on possible disparate impacts. The hope that
we will be able to continue to avoid rationing ventilators
must not stand in the way of revising guidance in a way
that better promotes health equity and racial justice,
both to be prepared, and given the significant expressive
value of ventilator guidance.
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Withholding or withdrawing life-saving ventilators
can become necessary when resources are insufficient. So far, US hospitals have been able to avoid
rationing ventilators. But we are still in the middle
of the pandemic. Easing lockdown measures, and
future waves, especially when combined, can still
make wrenching decisions necessary that clinicians
abroad faced during peak impact periods. In the
USA, rationing has unique social justice dimensions.
Dominant allocation frameworks aim to maximise utility, but insufficiently reflect critical equity
concerns. In particular, they disadvantage Black
communities—who already experience a disproportionate burden of COVID-19-related job losses,
hospitalisations and mortality,1–3 against a background of historical and structural disadvantage
in healthcare4–6 and common disregard for basic
health needs.7 Given how race and race correction

are used in modern medical decision-making, evaluating ventilator rationing protocols is crucial.

BACKGROUND

Imagine this hypothetical scenario: An intensive
care unit (ICU) in a larger metropolitan hospital
has 12 ventilators. Eleven are in use. Three criti19
cally ill patients with equally severe COVID-
symptoms qualify for admission. All three have
developed respiratory failure requiring use of a
ventilator. John is a 55- year-old white accountant.
He has comprehensive employer-sponsored health
insurance, and is from a well-off suburb, with an
average life expectancy of 85 years.8 He is generally healthy but has alcohol dependence. James is
a currently unemployed Black sales assistant, also
55. He has poorly controlled hypertension, mild
chronic kidney disease and asthma, and lives in a
worse-
off neighbourhood where many die some
25 years earlier than in John’s neighbourhood.8
Martin, a recently furloughed hotel worker, is also
Black and 55, and from a neighbourhood with an
average life expectancy of 70 years.8 He has severe
diabetes and advanced chronic kidney disease.
Treating patients equally should be a central goal
of medicine. Three main approaches could be taken
to allocate the remaining ventilator. First, a lottery
could give everyone a seemingly equal chance.
However, there is no baseline equality: James’ and
Martin’s poor health reflects historical and structural disadvantages,4 5 and conversely, historical and
structural advantages shaped John’s better health.
In a just society, poor health would be distributed equally across racial and income groups. Yet,
in ours, it is not. Structural factors such as more
favourable work, living and housing situations,
better access to public health measures and health
insurance are reasons the white majority enjoy on
average better general health and life expectancy.
An unqualified lottery would therefore simultaneously further increase John’s past advantage, and
reaffirm and compound9 James’ and Martin’s prior
disadvantage. Perhaps James and Martin should
therefore be given a second option: proportionately
higher chances through a weighed lottery. Third
is the current dominant model, which, in consequence, has the opposite impact: it simultaneously
increases John’s chances and decreases James’ and
Martin’s.

COVID-19 TRIAGE IN POLICY AND PRACTICE

The dominant model abstracts from concrete historical and social contexts.10 It relies on the premise
that ventilators would be wasted on someone who
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Figure 1 New Jersey policy on prioritising ventilator access by integrating SOFA and life expectancy scores in a point
system.13

might die while being ventilated, or might die soon after leaving
the hospital. Instead, to save the most lives, and life years, those
who are most likely to survive treatment, and to live sufficiently
long afterwards, should be selected—whoever this may be.
The dominant model can be justified by different versions of
consequentialism, or by so-called multicriteria approaches that
combine several values and principles.11 12 For example, like
other states, New Jersey (NJ) adopted a multicriteria framework
in a Gubernatorial Directive with a goal to do ‘the greatest good
for the greatest number’.13 Using NJ’s Directive as a concrete
example, we illustrate how such approaches compound disadvantage for Black patients. Naturally, there are direct implications for states or hospitals with identical or similar approaches.
NJ’s Directive aims to guide practitioners, provide transparency and bar the states’ agencies from bringing criminal prosecutions against healthcare facilities adopting the rationing
guidance. Ventilator access is determined by assigning each
patient a numerically ranked score, ‘based on objective medical
knowledge’.13
A central and widely used14 15 tool is the Sequential Organ
Failure Assessment (SOFA)16 that assesses eight separate
measures to compute an overall score for predicting the likelihood of death in the ICU. The higher the score, the more likely
a patient’s death. NJ’s Directive combines the SOFA score with
another score assessing near-term survival to produce an overall
raw score. This raw score is then used to assign patients to
priority groups (see figure 1).
To determine how well kidneys work, SOFA incorporates
creatinine, a waste product of muscles, found in blood. The
main problem with creatinine is that it is myopic to view it as
an objective measure of kidney function alone: it simultaneously
measures social disadvantages that may cause higher creatinine.
(The same point applies to considering existing comorbidities in
ways that reduce chances of receiving a ventilator, as five of the
published state frameworks do.15)
Some literature has suggested uniform differences in creatinine
levels by race, and historically higher average creatinine levels
in Black people have been attributed to higher muscle mass.17
However, there is weak scientific evidence for this hypothesis,
and increasing awareness that measuring differences across
races is severely complicated by the fact that race is a social
construct.18 19 Further, a biological trait cannot be mapped categorically onto a group of people that is both socially defined and
composed of widely differing physiological profiles that reflect
different circumstances of living far more than genetics.20 21 For
example, limited evidence suggests that genetic factors substantially increase the risk of end-stage kidney disease in 13% of
Schmidt H, et al. J Med Ethics 2022;48:126–130. doi:10.1136/medethics-2020-106856

African Americans,22 but even then, by implication, the vast
majority of the higher prevalence of the disease is non-genetic,
and due to different living circumstances that are more common
for the respective group.6 Relatedly, creatinine is higher in Black
communities because of higher rates of chronic kidney disease,
due to higher rates of diabetes and high blood pressure,23 24 that
are best understood as the consequences of health inequities and
structural racism.4–6
Creatinine becomes relevant for social justice due to the way
SOFA functions and is integrated into NJ’s Point System. SOFA
measures creatinine in five tiers. The first assigns 0 point to
patients with levels <1.2 mg/dL. This does not negatively affect
patients’ chances of receiving a ventilator (figure 1). However, 1
point is assigned for levels 1.2–1.9, and up to 4 for levels ≥5. A
single added point can make the difference between getting, and
not getting, a ventilator.
Let’s return to John, James and Martin. Assume that John has
a creatinine level of 1.18 (within the normal range).25 On SOFA,
he receives no points for creatinine, but for acute respiratory
impairment and his other health conditions, including a higher
bilirubin score due to liver disease from his alcohol dependence:
his overall SOFA score is 6.26 There is not a disproportionately
higher incidence of alcohol-related liver disease among white
people: the risk of a higher score due to bilirubin is equal for all
three individuals.27 Since John is estimated to live more than 5
years on discharge, his total raw score is 1, with assignment to
the high priority group.
James’ SOFA score is largely identical to John’s. He, too,
has acute respiratory impairment and, in addition, receives an
extra creatinine point due to his mild chronic kidney disease
(level=1.4),25 His total SOFA score is 7, translating into 2
points on the Point System. His advanced diabetes and poorly
controlled hypertension (reasons that many in his neighbourhood die decades before those in other neighbourhoods) result
in his remaining posthospital survival being estimated at less
than 5 years. He receives 2 additional points, an overall raw
score of 4, and intermediate priority classification.
Martin’s creatinine is the highest at 4.1, scoring 4 on SOFA.
Like John and James, his acute respiratory impairment registers on the SOFA subscore, as do his other health conditions
that again reflect prior structural disadvantage and are scored
at 8; his total SOFA score is 12. While his health is poor, he is
not estimated to die within 5 years because his wife has been
medically cleared to pre-emptively donate a kidney to him.
But the Point System assigns him to the intermediate priority
group.
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NJ’s scoring algorithm therefore means that John will receive
the ventilator, while James and Martin will be ‘reassess[ed] as
needed’.13

THE WAY FORWARD

When asked to explain the disproportionate impact of COVID-19
on Black communities (with, on average, twice and up to
sixfold higher mortality rates compared with whites3), Secretary of Health Alex Azar recently posited ‘higher risk profiles’
as causes.28 James’ and Martin’s failure to qualify for ventilators might likewise be explained by reference to risk factors,
captured numerically through value-neutral objective measures.
But justice in healthcare, and establishing fair rationing protocols, require a focus on the causes, and on the causes of the
causes, of poor health.29–31
Higher creatinine levels are not distributed equally across the
population, but are clustered in ways that stem from structural
inequalities. Despite appearing objective, SOFA’s conceptualisation of creatinine in interaction with guidance such as NJ’s
Directive gives Black people a lesser chance at receiving a ventilator, compounding prior injustice and embedding structural
racism, even if unintended.
So how should decision makers proceed? We consider seven
possible options arranged from the least to the most comprehensive type of changes: improving diversity in decision processes,
adjusting creatinine scores, replacing creatinine, dropping creatinine, finding alternative measures, adding equity weights and
rejecting the SOFA (and point score) model. We focus on SOFA,
as the best available data suggest that it is the most widely used
assessment tool (of 26 states with publicly available ventilator
guidelines, 15 recommend using SOFA).15 In many ways, the
discussion equally applies to other assessment tools (such as
modified SOFA, ASA) but in the interest of clarity we centre the
discussion on the dominant model.

Processes: improving diversity

One helpful suggestion is to require ‘triage officers and appeals-
committee members to have some expertise in equity, and to
come from diverse backgrounds’.2 Such steps are necessary since
SOFA unfairly advantages white patients, and disadvantages,
particularly, Black patients. Potentially, these measures could help
with valuing lives more equally and reducing probable implicit
bias,32 particularly when assessing remaining life expectancy.
For example, 40-year-old men with chronic kidney disease live
between 9 and 30 more years.33 To some clinicians, James’ likely
death within 5 years may be self-evident, and justify assigning
two extra points. But others, more familiar with his situation
and looking at options through a health equity lens,10 34 35 might
be more sceptical.
Still, when it comes to creatinine, equity training or diverse
backgrounds seem unlikely to counter its impact, which, when
challenged, will likely be justified as unassailable ‘objective
medical knowledge’.13 Improving diversity in processes might
therefore improve chances for James (who might not receive
points for reduced life expectancy), but not for Martin (whose
higher creatinine levels will deprive him of the high priority
group, regardless).

Adjusting creatinine

A more direct way of eliminating SOFA’s built-in bias against
Black patients could be to adjust creatinine penalties by race.
Instead of a ‘colourblind’ single creatinine threshold, NJ’s
Directive could account for the fact that the noted structural
128

factors—particularly higher levels of advanced chronic kidney
disease36—imply higher chances of increased creatinine levels in
Black populations. The SOFA point threshold could be adjusted
by tying the 1 point penalty not to a single creatinine threshold,
but to average levels, differing for races. This could avoid
unfairly advantaging John, would instantly level the playing field
for James and at least improve Martin’s chances.
The absence of creatinine race correction in ventilator
rationing is noteworthy: creatinine is routinely adjusted by race
in calculators used to determine medical care,21 including for
rationing kidney transplants.37 Only, there, race correction has
the opposite effect: adjusting creatinine can make Black patients
ineligible for treatment,17 and can delay kidney transplant evaluation referrals.38 The opportunity to avoid reducing Black
patients’ ventilator chances by adopting the routinely used race
correction was nevertheless passed up.
While adjusting scores in this way could immediately improve
James’ and Martin’s chances, the main, and important, downside
is that it could be viewed as supporting harmful race corrections
that rely on assumptions of race-based biological differences,
and thus promote the false view of race as a biological rather
than social category.

Dropping creatinine

Perhaps the simplest option would be to eliminate creatinine
from SOFA. John’s unfair advantage would be eliminated along
with James’ and Martin’s unfair disadvantage: all three would
be equals.
The principal challenge to this proposal is the power of path
dependency. Clinicians routinely use kidney function (in addition to pulmonary, cardiac and liver functions) as an important
measure of overall health. Clinicians and administrators would
be extremely reluctant to risk compromising SOFA’s overall validation and lose an integral measure in an approach that is widely
used.14 15

Alternative measures

An alternative might be to replace creatinine with biomarkers
estimating kidney function without variations across races.
Studies have demonstrated that cystatin C is promising in this
regard.39 40 Still, John’s unfair advantage would continue, along
with James’ and Martin’s unfair disadvantages, due to the
disproportionate prevalence of kidney disease among the two
racial groups.36 In addition, for the present context, cystatin C
has not been validated as part of SOFA.

Adding equity weights

A more pragmatic approach would seek not to interfere with the
basics or internal mechanics of currently established evaluation
frameworks, but to add feasible corrective measures that can
mitigate disparate impact.41 42
Here, John, James and Martin could all be evaluated via SOFA
and a point system such as NJ’s. However, a social disadvantage
score could then be added, such that James’ and Martin’s scores
improve in ways that offset, at least, their creatinine penalties.
The above-
cited data on the correlation of zip code, life
expectancy and COVID-19-related impact are irrefutable. Area
deprivation index (ADI) data43 capture them in ways that can be
integrated easily.
The ADI has already been used for targeting health services.43
Developing and amplifying prior proposals,44 45 a recent report
by the National Academy of Sciences, Engineering, and Medicine set out a similar approach for equitable vaccine allocation.46
Adjusting by disadvantage would also build on precedent of
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rationing in other areas with major social justice implications,
such as school access. So-called reserve systems have been used
to ensure that ‘colourblind’ assessments (focusing exclusively
on ‘objective’ entry examination results) no longer disproportionately privilege the better-off, but also provide allocations for
off populations, with recent adaptations for ventilator
worse-
rationing.47 Equity weights can instantly eliminate John’s unfair
advantage, and James’ and Martin’s unfair disadvantage. While
practically straightforward, the strongest challenge is a legal
one.48 However, given that a major part of what explains the
consequences of structural racism has to do with unjust law, and
given that, by implication, it is current law that confers more
benefits to the white majority who were already more privileged to start with, there is likely no better time for revisiting the
underlying legal justification than now.

Dropping SOFA

The most radical approach would be dropping SOFA altogether.
The American College of Chest Physicians noted considerable
concern about SOFA in its recent COVID-19 guide: ‘a growing
body of evidence suggests such scoring systems are unlikely to
predict critical care outcomes with sufficient accuracy,… or be
for a useful basis for triage decisions based upon the current
protocol cut points’.49 Disability rights groups have identified
further problems, for example, that SOFA penalises pre-existing
speech disability due to its reliance on the Glasgow Coma Scale,
noting also that states like California (with an approach very
similar to NJ’s) failed to sufficiently solicit public comments on
its triage rules.50
Yet, for James and Martin, the implications of abandoning
SOFA (or similar creatinine-integrating measures, such as LAPS2
(Laboratory Acute Physiology Score)) are not obvious. Martin
might be assigned to the high priority group. But post-treatment
survival could loom even larger, and James might continue to be
disadvantaged.
Ultimately, the question of the role of SOFA and point systems
is about the extent to which such approaches should be sensitive to, or ignore, social justice implications. The dominant
approach appeals to many clinicians as its seemingly objective
numeric records can be verified in the same way by different
laboratories, be recorded easily in charts and be used to track
patients’ progress. Yet, it is not neutral—but has baked into it
factors that advantage John. The most radical approach would
flip the assessment, and in allocating scarce resources would not
give priority to those who already had more previously. Instead,
the protocol could have preference for those who received the
least, without fraught assessments of posthospital survival, and
focus only on avoiding allocating treatment to those certain to
die during its course.

CONCLUSION

A final option is simply to leave things as they are. One might
agree that it is tragic that COVID-19-associated morbidity and
mortality directly mirrors more general morbidity and mortality
inequities across races and zip codes—but nonetheless argue
that a pandemic is the wrong time to implement what seems like
affirmative action for ventilators. Moreover, opening the discussion now could risk regressing to oftentimes worse approaches,
such as first come, first served.
We disagree. First, it is wrong to view as neutral that John
has higher chances for a ventilator under the current allegedly
objective ‘colourblind’ SOFA/point score system, and to ignore
that it compounds James’ and Martin’s lower prior unfair
Schmidt H, et al. J Med Ethics 2022;48:126–130. doi:10.1136/medethics-2020-106856

disadvantage.9 Second, failing to implement any measure that
can mitigate the effect that creatinine scores reduce Black
people’s fair chances for ventilators will only exacerbate the
dramatic impact COVID-19 has on disadvantaged populations,
possibly contributing to lasting social trauma and injustice.41
We have offered above six potential ways to respond, each
with discrete advantages and disadvantages. In the regrettable
absence of fair federal guidance, hospital and state-level policymakers should reflect on which of these, or further options,
seem feasible and justifiable. In any case, all guidance should
be supplemented with a monitoring and reporting requirement
on possible disparate impacts of the ultimately adopted policy.
Specifically, there needs to be clear accounting on whether there
are differences across racial and income groups in terms of who
receives ventilators, and who is removed from them.51 52
Further, the dominant approach itself should be subject to
broader public evaluation. It is unclear on what grounds prioritising prognosis via SOFA and life expectancy (even if limited to
5 years) expresses valuing all lives equally. Qualitative research
(cited as having informed the NJ guidance3) illustrates this.
Researchers elicited, separately, views of participants from an
affluent suburb (Howard County), and from a worse-off inner-
city neighbourhood (East Baltimore). Eighty-three per cent of
suburban respondents thought ‘priority to those most likely to
survive’ would be an acceptable principle, 83% (finding it by far
the most acceptable of six principles), compared with only 33%
from the inner city.53 Ventilator rationing guidance such as NJ’s
therefore needs to be informed more fully by a more diverse
range of voices.
Hopefully, we will be able to continue to avoid rationing
ventilators. But such hope must not stand in the way of revising
guidance in a way that better promotes health equity and racial
justice, both to be prepared, and given the significant expressive
value of ventilator guidance.
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